Encompass Health Corp (EHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600M 1.2B 1.8B Q3 '21: 1B Q4 '21: 1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.1B Q4 '22: 1.1B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.2B Q4 '23: 1.2B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.4B Q4 '24: 1.4B Q1 '25: 1.5B Q2 '25: 1.5B Q3 '25: 1.5B Q4 '25: 1.5B Q1 '26: 1.6B Q2 '26: 1.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 60M 120M 180M Q1 '18: 150M Q2 '18: 157.3M Q3 '18: 154.5M Q4 '18: 93.4M Q1 '19: 167.1M Q2 '19: 152.6M Q3 '19: 151.2M Q4 '19: 141.2M Q1 '20: 159.3M Q2 '20: 85.2M Q3 '20: 151.1M Q4 '20: 168.3M Q1 '21: 143M Q2 '21: 146.8M Q3 '21: 141.4M Q4 '21: 128.4M Q1 '22: 131.5M Q2 '22: 128.6M Q3 '22: 127.5M Q4 '22: 151.9M Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Net Income Quarterly

0 70M 140M 210M Q3 '21: 100M Q4 '21: 91.6M Q1 '22: 87.5M Q2 '22: 48.7M Q3 '22: 45.4M Q4 '22: 89.4M Q1 '23: 87.7M Q2 '23: 91.4M Q3 '23: 85.3M Q4 '23: 87.6M Q1 '24: 112.5M Q2 '24: 114.1M Q3 '24: 108.2M Q4 '24: 120.9M Q1 '25: 151.5M Q2 '25: 142.1M Q3 '25: 126.5M Q4 '25: 146.1M Q1 '26: 194.5M Q2 '26: 153.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 150M 300M 450M Q3 '21: 177.6M Q4 '21: 123.8M Q1 '22: 218.9M Q2 '22: 244.6M Q3 '22: 70.1M Q4 '22: 172.2M Q1 '23: 227.9M Q2 '23: 206.7M Q3 '23: 215.2M Q4 '23: 201M Q1 '24: 238.8M Q2 '24: 217.4M Q3 '24: 267.8M Q4 '24: 278.8M Q1 '25: 288.6M Q2 '25: 270.2M Q3 '25: 270.8M Q4 '25: 346M Q1 '26: 313.1M Q2 '26: 282.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-120M -60M 0 60M 120M 180M Q3 '21: 58M Q4 '21: -68.5M Q1 '22: 106M Q2 '22: 131.9M Q3 '22: -79.2M Q4 '22: -17.7M Q1 '23: 131.3M Q2 '23: 89.5M Q3 '23: 68.5M Q4 '23: -10.7M Q1 '24: 99.4M Q2 '24: 60.5M Q3 '24: 120.3M Q4 '24: 80.1M Q1 '25: 125.5M Q2 '25: 113.3M Q3 '25: 83.7M Q4 '25: 116.7M Q1 '26: 150.7M Q2 '26: 62.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '20: 99.6M Q2 '20: 99.9M Q3 '20: 99.9M Q1 '21: 100.2M Q2 '21: 100.2M Q3 '21: 100.2M Q1 '22: 100.2M Q2 '22: 100.3M Q3 '22: 100.5M Q1 '23: 100.9M Q2 '23: 101.1M Q3 '23: 101.4M Q1 '24: 102.2M Q2 '24: 102M Q3 '24: 102.1M Q1 '25: 102.1M Q2 '25: 102.3M Q3 '25: 102.3M Q1 '26: 100.6M Q2 '26: 100M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '21: 4.06 Q4 '21: 4.11 Q1 '22: 3.91 Q2 '22: 3.27 Q3 '22: 2.72 Q4 '22: 2.70 Q1 '23: 2.70 Q2 '23: 3.11 Q3 '23: 3.50 Q4 '23: 3.46 Q1 '24: 3.69 Q2 '24: 3.91 Q3 '24: 4.13 Q4 '24: 4.46 Q1 '25: 4.84 Q2 '25: 5.11 Q3 '25: 5.29 Q4 '25: 5.54 Q1 '26: 5.99 Q2 '26: 6.14 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.